Hideaki Ogiwara
6PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 15, 2026
A GCLC Inhibitor Enhances the Antitumor Efficacy of Glutathione Metabolic Pathway Inhibition in SMARCB1-Deficient Rhabdoid Tumors.Mariko Takeuchi, Yoshinori Ishikawa, Takuya Okada
|Feb 27, 2026
ARID1A Deficiency in Diffuse-Type Gastric Cancer Promotes a Pyrimidine Metabolic Vulnerability.Harumi Hirano, Hideki Makinoshima, Hideaki Ogiwara
|Mar 13, 2025
Targeting USP8 causes synthetic lethality through degradation of FGFR2 in ARID1A-deficient ovarian clear cell carcinoma.Ryosuke Saito, Makoto Fukushima, Mariko Sasaki
|Dec 03, 2024
Efficacy of CBP/p300 Dual Inhibitors against Derepression of KREMEN2 in cBAF-Deficient Cancers.Mariko Sasaki, Daiki Kato, Hiroshi Yoshida
|Jun 05, 2024
Targeting dependency on a paralog pair of CBP/p300 against de-repression of KREMEN2 in SMARCB1-deficient cancers.Mariko Sasaki, Daiki Kato, Karin Murakami
|Jan 20, 2020
Synthetic lethal therapy based on targeting the vulnerability of SWI/SNF chromatin remodeling complex-deficient cancers.Mariko Sasaki, Hideaki Ogiwara
Pageof 1
Frequent Collaborators
5 joint publications
Mariko Takeuchi
2 joint publications
Hiroshi Yoshida
1 joint publications
Shohei Takase
1 joint publications
Daiki Kato
1 joint publications
Takafumi Shimizu
1 joint publications
Harumi Hirano
1 joint publications
Hideki Makinoshima
1 joint publications
Yoshinori Ishikawa
1 joint publications
Takuya Okada
1 joint publications
Ryohei Kozaki
